Ultralife Corp (ULBI) — SEC Filings

Ultralife Corp (ULBI) — 25 SEC filings. Latest: 8-K (Nov 18, 2025). Includes 9 8-K, 6 10-Q, 2 DEF 14A.

View Ultralife Corp on SEC EDGAR

Overview

Ultralife Corp (ULBI) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Nov 18, 2025: Ultralife Corporation filed an 8-K on November 18, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. The filing details the company's financial performance and provides supporting documentation. Ultralife Corporation, incorporated in

Sentiment Summary

Across 25 filings, the sentiment breakdown is: 1 bullish, 2 bearish, 22 neutral. The dominant filing sentiment for Ultralife Corp is neutral.

Filing Type Overview

Ultralife Corp (ULBI) has filed 9 8-K, 6 10-Q, 2 DEF 14A, 2 10-K/A, 2 10-K, 1 8-K/A, 1 SC 13D/A, 1 SC 13G, 1 SC 13G/A with the SEC between Feb 2024 to Nov 2025.

Filings by Year

2025 · 2024

Recent SEC Filings (25)

Ultralife Corp SEC Filing History
DateFormDescriptionRisk
Nov 18, 20258-KUltralife Corp Files 8-K on Financialslow
Nov 17, 202510-QULBI Revenue Jumps 18% on Acquisition, But Net Income Plummets 75%high
Aug 27, 20258-KUltralife Corp Appoints New Auditor BDO USA, LLPmedium
Aug 7, 202510-QULTRALIFE Q2 Revenue Jumps 20% on Strong Battery, Comms Demandmedium
Jul 17, 20258-KUltralife Corp (ULBI) Files 8-K on Shareholder Votemedium
May 27, 2025DEF 14AULTRALIFE Details Executive Equity Awards in Latest Proxy Filinglow
May 12, 202510-QUltralife Corp. Q1 Revenue Down, Net Loss Widensmedium
May 9, 20258-KUltralife Corp Files 8-K on Financialslow
Apr 28, 202510-K/AUltralife Corp Files 2024 10-K Amendmentlow
Apr 1, 202510-KUltralife Corp Files 2024 10-Kmedium
Jan 16, 20258-K/AUltralife Corp Files 8-K/A Amendmentlow
Nov 12, 202410-QUltralife Corp. Files Q3 2024 10-Q, Details Term Loanmedium
Nov 8, 20248-KUltralife Corp Files 8-K on Financialslow
Nov 6, 20248-KUltralife Corp Completes Acquisition, Enters New Agreementsmedium
Oct 3, 20248-KUltralife Corp Files 8-K: Material Definitive Agreementmedium
Sep 3, 2024SC 13D/AWhitmore Amends Ultralife Corp Stake Filingmedium
Jul 25, 202410-QUltralife Corp. Q2 2024 Revenue Hits $21.1Mmedium
Jul 17, 20248-KUltralife Corp Files 8-K on Shareholder Vote Matterslow
May 29, 2024DEF 14AUltralife Corp Files Definitive Proxy Statementlow
Apr 26, 202410-K/AUltralife Corp Files 10-K/A Amendment for Fiscal Year Ended December 31, 2023low

Risk Profile

Risk Assessment: Of ULBI's 24 recent filings, 1 were flagged as high-risk, 12 as medium-risk, and 11 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Ultralife Corp Financial Summary (10-Q, Nov 17, 2025)
MetricValue
Revenue$142,678
Net Income$1,524
EPS($0.07)
Debt-to-Equity0.34
Cash Position$9,260
Operating Margin-2.2%
Total Assets$222,246
Total Debt$50,300

Key Executives

  • Mr. Manna
  • Mr. Fain
  • Bradford T. Whitmore

Industry Context

Ultralife Corporation operates in the battery and energy storage solutions market. This industry is characterized by rapid technological advancements, increasing demand for high-performance and long-lasting batteries, and a growing focus on sustainability and alternative energy sources. Competition is intense, with established players and emerging companies vying for market share.

Top Tags

SEC Filing (4) · financial-reporting (3) · 8-k (3) · earnings (3) · amendment (3) · Ultralife Corp (3) · financial-statements (2) · acquisition (2) · debt (2) · shareholder-vote (2)

Executive Compensation

From the most recent DEF 14A filing (May 27, 2025):

  • Mr. Manna — President and CEO
  • Mr. Fain — CFO, Treasurer and Secretary

Key Numbers

Ultralife Corp Key Metrics
MetricValueContext
Total Revenues (9 months)$142,678Increased from $120,604 thousand in 2024, an 18.3% increase.
Net Income Attributable to Ultralife Corporation (9 months)$1,524Decreased from $6,118 thousand in 2024, a 75.1% decline.
Net Loss (3 months)($1,247)Compared to net income of $279 thousand in the prior year, a significant reversal.
Electrochem Acquisition Price$48,022Funded through a new credit agreement, impacting debt levels.
Electrochem Revenue Contribution (9 months)$23,718Significant portion of the overall revenue increase.
Term Loan Outstanding$50,937As of September 30, 2025, part of the new credit agreement.
Acquisition Transaction Costs (9 months)$607Included in selling, general and administrative expense.
Diluted EPS (3 months)($0.07)Compared to $0.02 in the prior year, indicating a loss per share.
Q2 2025 Revenue$36.8MIncreased 20.3% from $30.6M in Q2 2024
H1 2025 Revenue$70.5MIncreased 18.5% from $59.5M in H1 2024
Q2 2025 Net Income$3.5MIncreased 250% from $1.0M in Q2 2024
Q2 2025 Diluted EPS$0.18Increased from $0.05 in Q2 2024
Battery & Energy Products Segment Revenue Growth15.0%Segment revenue reached $28.5M in Q2 2025
Communications Systems Segment Revenue Growth45.0%Segment revenue reached $8.3M in Q2 2025
Date of Earliest Event Reported20250716Indicates the date of the shareholder vote event.

Related Companies

EAC · ENR

Frequently Asked Questions

What are the latest SEC filings for Ultralife Corp (ULBI)?

Ultralife Corp has 25 recent SEC filings from Feb 2024 to Nov 2025, including 9 8-K, 6 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of ULBI filings?

Across 25 filings, the sentiment breakdown is: 1 bullish, 2 bearish, 22 neutral. The dominant sentiment is neutral.

Where can I find Ultralife Corp SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Ultralife Corp (ULBI) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Ultralife Corp?

Key financial highlights from Ultralife Corp's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for ULBI?

The investment thesis for ULBI includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Ultralife Corp?

Key executives identified across Ultralife Corp's filings include Mr. Manna, Mr. Fain, Bradford T. Whitmore.

What are the main risk factors for Ultralife Corp stock?

Of ULBI's 24 assessed filings, 1 were flagged high-risk, 12 medium-risk, and 11 low-risk.

What are recent predictions and forward guidance from Ultralife Corp?

Forward guidance and predictions for Ultralife Corp are extracted from SEC filings as they are enriched.

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.